Rx only · Tablet, Film Coated, Extended Release · Oral

Niacin

2 ACTIVE SUPPLIERS — US

openFDA · updated weekly

US4 NDCs
2 active makers

UKComing
soon

CAComing
soon

AUComing
soon

EUComing
soon

ATCC04AC01

RxCUI (US)7393

US makers2 labelers

Packages17

DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.274

Latest avg · Jul 22, 2026

+8%

Since Dec 17, 2025

Active US suppliers

100%

Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.0K

Rx · 2026 Q1

47K

Units dispensed

+31%

Rx vs. year ago

Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
SUN PHARMACEUTICAL INDUSTRIES, INC.	unknown	14	SUPPLYING
Amneal Pharmaceuticals LLC	unknown	3	SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Jan 18, 2024
RECALLRecall (Class II): Niacin Extended-Release Tablets, USP 1000mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industr…
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA
Jan 18, 2024
RECALLRecall (Class II): Niacin Extended-Release Tablets, USP 500mg, Rx Only, 90 Tablets per bottle, Distributed by: Sun Pharmaceutical Industri…
CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the USA